39.37USD+0.45%Mkt Cap: 2.80B USDP/E: —Last update: 2026-05-26
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap2.80B USD
Enterprise Value6.79B USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-141.20M USD
Revenue/Share—
Last Price39.37 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees220
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-19.88
PEG—
EV/EBITDA-31.14
EV/Revenue—
P/S—
P/B1.81
EPS (TTM)-2.64
EPS (Forward)-1.95
52W Range
15.8030% of range94.90
52W High94.90 USD
52W Low15.80 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-9.31%
ROA-8.91%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-222.20M USD
CapEx (TTM)3.61M USD
FCF Margin—
FCF Yield—
Net Debt-1.45B USD
Net Debt/EBITDA6.66
Balance Sheet
Debt/Equity0.00
Current Ratio26.16
Quick Ratio25.59
Book Value/Sh21.41 USD
Cash/Share6.863 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)106.47 USD
Target Range69.50 USD – 145.00 USD
# Analysts16
Ownership
Shares Out.71.07M
Float164.69M
Insiders2.66%
Institutions96.06%
Short Interest
Short Ratio6.0d
Short % Float11.52%
Short % Out.8.40%
Shares Short5.97M
Short (prev mo.)5.76M
Technical
SMA 5046.62 (-15.6%)
SMA 20046.13 (-14.7%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)825.04K
Avg Vol (10d)699.84K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—